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Genetic defects in the microRNA (miRNA) generating
enzyme, dicer, are increasingly linked to disease.
Loss of miRNA in dicer deficiency is thought to
be due to loss of miRNA-generating activity. Here,
we demonstrate a catabolic mechanism driving
miRNA depletion in dicer deficiency. We developed
a Dicer-antagonist assay revealing a pre-miRNA
degrading enzyme that competes with pre-miRNA
processing. We purified this pre-miRNA degrading
activity using an unbiased chromatographic proce-
dure and identified the ribonuclease complex Trans-
lin/Trax (TN/TX). In wild-type dicer backgrounds,
pre-miRNA processing was dominant. However, in
dicer-deficient contexts, TN/TX broadly suppressed
miRNA. These findings indicate that miRNA deple-
tion in dicer deficiency is due to the combined loss
of miRNA-generating activity and catabolic function
of TN/TX. Importantly, inhibition of TN/TX mitigated
loss of bothmiRNA and tumor suppressionwithdicer
haploinsufficiency. These studies reveal a potentially
druggable target for restoringmiRNA function in can-
cers and emerging dicer deficiencies.
INTRODUCTION
As the central miRNA-generating enzyme, Dicer is essential for
proper physiological function (Bernstein et al., 2003). miRNA
originate as long primary transcripts that are processed to pre-
cursor (pre-) miRNA by a complex comprised of the RNaseIII
Drosha and RNA binding partner DGCR8/Pasha (Lee et al.,
2003; Denli et al., 2004; Gregory et al., 2004; Han et al., 2004).
Following export from nucleus to cytoplasm (Yi et al., 2003;
Lund et al., 2004), the miRNA-generating enzyme, consisting of
the RNaseIII Dicer and RNA binding partner TRBP, processes
pre-miRNA to mature miRNA (Bernstein et al., 2001; Hutva´gner
et al., 2001; Lee et al., 2004, 2006; Chendrimada et al., 2005;
Haase et al., 2005; Paroo et al., 2009). Mature miRNA programCell ReArgonaute proteins to effect sequence-specific transcript
silencing (Hammond et al., 2001; Liu et al., 2004; Meister et al.,
2004).
miRNA expression is a net product of synthesis and degrada-
tion at each stage of maturation. Catabolic regulation of RNAi
was introduced through a mutagenesis screen in C. elegans,
which identified eri-1 as a small interfering RNA (siRNA)-degrad-
ing nuclease (Kennedy et al., 2004). Subsequently, related
members of the DEDD family, sdn1–4, were found to promote
turnover of a subset of miRNA in Arabidopsis (Ramachandran
and Chen, 2008). A candidate approach also revealed xrn-2 as
a catabolic regulator of select miRNA in C. elegans (Chatterjee
and Grosshans, 2009). In mammals, a targeted study of immune
response genes found that MCPIP1 aberrantly cleaved and inac-
tivated pre-miRNA (Suzuki et al., 2011). The ER-stress-respon-
sive IRE1awas shown to digest precursors ofmiRNA that govern
apoptosis (Upton et al., 2012). The Dis3l2 exonuclease was
found to degrade Lin28-TUT-4 polyuridylated pre-let-7 (Viswa-
nathan et al., 2008; Heo et al., 2008, 2009; Hagan et al., 2009;
Chang et al., 2013). Further understanding of catabolic regula-
tion of the miRNA pathway would be facilitated through unbi-
ased, functional approaches.
A striking molecular signature of tumors is widespread loss
of miRNA relative to nontumor tissue (Lu et al., 2005; Lee et al.,
2008; Ozen et al., 2008; Maillot et al., 2009; Dvinge et al.,
2013). Experimental depletion of miRNA through genetic disrup-
tion of the biogenesis machinery promoted cellular transforma-
tion and tumorigenesis in mice (Kumar et al., 2007, 2009). Clini-
cally, hemizygous deletion of dicer is observed in up to 40% of
human tumors and is associated with poor patient prognoses
(Table S1; Merritt et al., 2008; Kumar et al., 2009). These and
other studies have established dicer as a haploinsufficient tumor
suppressor (Kumar et al., 2009; Heravi-Moussavi et al., 2012;
Lambertz et al., 2010; Nittner et al., 2012; Ravi et al., 2012;
Mito et al., 2013). Medical genetics is rapidly expanding the
scope of dicer disorders.
Loss of miRNA in dicer deficiency is thought to be due to loss
of miRNA-generating activity. Here, we demonstrate that deple-
tion of miRNA in dicer deficiency is due to both loss of miRNA-
generating activity and catabolic function of Translin/Trax
(TN/TX). Inhibition of TN/TX mitigated loss of both miRNA andports 9, 1471–1481, November 20, 2014 ª2014 The Authors 1471
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veals a Pre-miRNA-Degrading Enzyme that
Competes with Pre-miRNA Processing
(A) In vitro miRNA-generating assays performed
with HeLa extract or soluble and pellet fractions
following ammonium sulfate precipitation.
(B) Immunoblotting of fractions for Dicer and
TRBP.
(C) Full-length, overexposed autoradiogram de-
picting pre-miRNA-degradation products.tumor suppression with dicer haploinsufficiency. A comple-
mentary catabolic mechanism integral to dicer deficiency ad-
vances understanding ofmiRNAdepletion in tumor development
and may represent a general mechanism for emerging dicer
deficiencies.
RESULTS
Identification of a Pre-miRNA Degrading Enzyme
In developing a biochemical purification scheme to isolate the
human miRNA-generating complex (Paroo et al., 2009), a num-
ber of observations suggested that dicing activity is subject to
negative regulation. For example, baseline miRNA-generating
activity from HeLa cell extract was relatively weak (Figure 1A,
lane 1). Fractionation of extract by ammonium sulfate precipita-
tion shifted miRNA-generating activity and the miRNA-gener-
ating machinery (Dicer/TRBP) to the pellet fraction (Figures 1A
and 1B). Notably, miRNA production in the pellet fraction was
greater than that of the original extract (Figure 1A, compare lanes
1 and 3). This suggested the presence of a miRNA-generating in-
hibitor in the soluble fraction. Reconstitution of supernatant and
pellet resulted in lower levels of miRNA production relative to
pellet alone (Figure 1A, compare lanes 3 and 4) and comparable
to that of the original extract. This further suggested a negative
regulator in the supernatant. Interestingly, upon overexposure
and analysis of full-length autoradiograms, pre-miRNA degrad-
ing activity became evident in the soluble fraction (Figure 1C,
lane 3). That both dicing and pre-miRNA degrading activity
were detected at relatively low levels in the starting extract (Fig-
ure 1C, lane 2), and that both activities were enhanced following
separation (lanes 3 and 4) suggested that these enzymes
compete for pre-miRNA substrate. Consistent with this, recon-
stitution of supernatant and pellet fractions reduced both dicing
and pre-miRNA degradation (lane 5).
To identify this pre-miRNA degrading enzyme, we developed
an unbiased, multistep chromatographic purification scheme
(Figure 2A). In the first stage of the protocol, we made use of
ammonium sulfate precipitation to isolate pre-miRNA degrading
activity frommiRNA-generating activity. Following the final Q Se-
pharose column, fractions were assayed for pre-miRNA degrad-
ing activity (Figure 2B) and resolved on a SDS-polyacrylamide1472 Cell Reports 9, 1471–1481, November 20, 2014 ª2014 The Authorsgel, and proteins were visualized by
silver staining (Figure 2C). Two bands
exhibited perfect correlation with pre-
miRNA degrading activity. That two pro-
teins exhibited identical chromatographicbehavior following such a stringent purification procedure sug-
gested the possibility of an enzymatic complex. Mass spectrom-
etry and sequencing analysis identified these constituents as
Translin (TN) and Trax (TX; Table S2). This identification is consis-
tent with recent studies demonstrating that TN and TX function
as a ribonuclease complex (Liu et al., 2009; Tian et al., 2011;
Ye et al., 2011). Subsequent immunoblotting of fractions
confirmed perfect chromatographic correlation between pre-
miRNA degrading activity and TN/TX (Figure 2D).
Pre-miRNA Degradation Competes with Pre-miRNA
Processing
To authenticate TN/TX as a pre-miRNA degrading enzyme, we
generated recombinant TN/TX complexes. Previous structure-
function studies indicated that TN serves as a scaffold for the
catalytic TX subunit (Liu et al., 2009; Tian et al., 2011; Ye
et al., 2011). We used a dual expression system to produce
wild-type and catalytically defective (E126A) TN/TX in E. coli
(Figure 3A). Wild-type, but not mutant TN/TX, yielded dose-
dependent pre-miRNA degrading activity (Figure 3B). These
findings indicate that our activity-guided chromatographic puri-
fication correctly identified TN/TX as a pre-miRNA degrading
enzyme.
Interestingly, TN/TX cleaved pre-miR-16 and pre-miR-21 effi-
ciently relative to pre-let7a (Figure 3B). Analysis of stem-loop
structures curated in miRBase (Griffiths-Jones, 2004) indicated
a distinguishing feature. Pre-miR-16 and pre-miR-21 bear
mismatch bulges in the stem regions, a characteristic shared
by most pre-miRNA (Figure 3C). In contrast, the pre-let-7a
stem harbors greater complementarity, lacking these canonical
bulges. RNase A/T1-guided mapping studies indicated that
TN/TX cleaved pre-miR-16 and pre-miR-21 at these unpaired re-
gions of the stem (Figure 3C, arrows). This is consistent with the
single-strand-specific endonuclease function of TN/TX (Liu et al.,
2009; Tian et al., 2011; Ye et al., 2011). As a direct test, we
removed mismatches on the stems of pre-miR-16 and pre-
miR-21 to generate short hairpin sh-miR-16 and sh-miR-21
with complementary stems (Figure 3C). These short hairpin
RNA (shRNA) constructs were cleaved much less efficiently
than pre-miRNA (Figure 3D). Thus, TN/TX degrades pre-miRNA
by cleaving mismatch bulges in their stems.
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Figure 2. Chromatographic Purification of a
Pre-miRNA-Degrading Enzyme
(A) Purification scheme of pre-miRNA-degrading
activity from HeLa cytoplasmic extract (S100).
Numbers indicate salt concentration (mM).
(B) Individual fractions from the final Q Sepharose
column were assayed for pre-miRNA-degrading
activity.
(C) Fractions were subjected to SDS-poly-
acrylamide gel electrophoresis and silver stained.
See also Table S2 for peptides identified by mass
spectrometry.
(D) Fractions were immunoblotted for Translin and
Trax.Because our initial fractionation studies indicated that pre-
miRNA degradation competes with pre-miRNA processing (Fig-
ure 1C), we sought to determine whether TN/TX could inhibit
miRNA production. We performed miRNA-generating assays
with a constant level of recombinant Dicer/TRBP and titrated in
wild-type or catalytically defective TN/TX. miRNA production
was inhibited with wild-type but not mutant complex, indicating
that TN/TX inhibits dicing in a nuclease-dependent manner
(Figure 3E). Moreover, TN/TX inhibited processing of pre-miR-
16 but not sh-miR-16, further indicating that substrate cleavage
is required for inhibiting dicing (Figure 3F). Dicer/TRBP and TN/
TX were found to compete similarly for pre-miRNA binding (Fig-
ure S1). Collectively, these findings indicate that pre-miRNA
degradation by TN/TX competes with pre-miRNA processing
by Dicer/TRBP.
To investigate a potential role for TN/TX in regulating miRNA
expression in vivo, we performed experiments with wild-type
and translin (tn)/ mice (Fukuda et al., 2008; Wu et al., 2011).
Given that TN/TX is abundant in testis and cerebellum (Chenna-
thukuzhi et al., 2003), these tissues were selected for study.
Because the scaffolding function of TN is required to stabilize
the catalytic TX subunit, tn/ mice are defective for both sub-
units (Figure 4A; Chennathukuzhi et al., 2003; Wu et al., 2011).
Consistent with our recombinant studies, extracts prepared
from tn/ mice yielded lower levels of pre-miRNA degradation
and higher levels of miRNA-generating activity compared with
wild-type (Figure 4B). We then performed miRNA profiling anal-
ysis of cerebellar RNA from wild-type and tn/ animals. These
studies revealed a small subset of miRNA suppressed by TN/
TX (Table S3). Consistent with in vitro studies, elevated miRNA
in tn/ mice was accompanied by higher levels of pre-
miRNA relative to wild-type (Figures 4C and 4D). Taken together,Cell Reports 9, 1471–1481, Nothese findings demonstrate that TN/TX
functions as a pre-miRNA degrading
enzyme, thereby reducing substrate for
the miRNA-generating machinery.
Loss ofmiRNA in dicerDeficiency Is
due to Loss of miRNA-Generating
Activity and TN/TX
The modest differences in miRNA
expression between wild-type and tn/
mice indicated that pre-miRNA werepreferentially processed to mature miRNA by Dicer/TRBP rather
than degraded by TN/TX. Yet, TN/TX markedly suppressed
in vitro miRNA-generating activity. We reasoned that when
dicer is fully functioning, miRNA-generating capacity sufficiently
compensates for TN/TX. However, when miRNA-generating ac-
tivity is limiting, TN/TX effectively competes with dicing. To
address this possibility, we made use of previously established
HCT116 human colorectal carcinoma cells encoding either
wild-type or dicer hypomorph alleles, in which exon 5 within
the helicase domain was genetically disrupted (dicerex5; Cum-
mins et al., 2006). Because expression of Dicer and TRBP is
interdependent (Chendrimada et al., 2005; Haase et al., 2005;
Lee et al., 2006; Paroo et al., 2009), dicer hypomorph cells ex-
hibited attenuated expression of both subunits of the miRNA-
generating enzyme and reduced miRNA-generating activity
(Figures S2A and S2B).
We established stable knockdown of TN/TX through lentivirus-
mediated shRNA expression in dicerwt and dicerex5 cells. As
observed with tn/ mice, knockdown of TN resulted in loss of
both the structural TN and catalytic TX subunits, whereas knock-
down of TX reduced expression of only the catalytic subunit (Fig-
ures 5A and 5B). Relative to control, depletion of TN and TX
attenuated pre-miRNA degradation and enhanced miRNA-
generating activity for both dicerwt and dicerex5 cells (Figures
5C and 5D). The slight functional differences between shTN
and shTX correspond to differences in knockdown efficiency.
To determine the importance of TN/TX in regulating cellular
miRNA, we conducted miRNA profiling studies. Consistent
with modest differences between wild-type and tn/ mice (in
which dicer was intact), TN/TX was found to have only minor
influence on miRNA expression in dicerwt cells (Figure 5E, blue
bars). However, in dicerex5 cells, TN/TX broadly suppressedvember 20, 2014 ª2014 The Authors 1473
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Figure 3. Pre-miRNA Degradation by TN/TX Competes with Pre-miRNA Processing by Dicer/TRBP In Vitro
(A) Colloidal-blue-stained polyacrylamide gel depicting wild-type (WT) and catalytic mutant (E126A) recombinant TN/TX complexes.
(B) Pre-miRNA degradation assays using indicated amounts of WT or catalytic mutant TN/TX. Assays were performed with synthetic pre-miR-16, pre-miR-21, or
pre-let-7a as indicated.
(C) Sequences and structures of pre-miRNA and short-hairpin RNA (shRNA) were obtained from miRBase and RNAfold. Arrows indicate cleavage sites
determined through mapping studies.
(D) Stem-loop degradation assays performed with indicated amounts of TN/TX and pre-miR-16, sh-miR-16, pre-miR-21, or sh-miR-21 as indicated.
(E) Pre-miRNA processing reactions were performed with 50 nM recombinant Dicer/TRBP and indicated amounts of either WT or catalytic mutant TN/TX.
(F) Stem-loop processing reactions performed with either pre-miR-16 or sh-miR-16, 50 nM Dicer/TRBP, and indicated amounts of TN/TX.miRNA expression (Figure 5E, red bars; Table S4). Interestingly,
miRNA that were most strongly downregulated in dicerex5 versus
dicerwt cells were those most strongly suppressed by TN/TX
(Figure 5F, upper-left quadrant). That is, loss of miRNA in dicer
defective cells was due to the combined effects of (1) the ex-
pected loss of miRNA-generating activity and (2) catabolic func-
tion of TN/TX.
We subsequently authenticated profiling studies using
miRNA-specific assays. In dicerwt cells, TN/TX had minor influ-
ence on miRNA expression (Figure S2C). However, in dicerex5
cells, depletion of TN/TX partially restored miRNA expression
relative to dicerwt. This further indicated that loss of miRNA in
dicerex5 cells was due to both loss of miRNA-generating activity
and TN/TX. Thus, although TN/TX inhibited in vitro miRNA-1474 Cell Reports 9, 1471–1481, November 20, 2014 ª2014 The Autgenerating activity for both dicerwt and dicerex5 cells (Figures
5C and 5D), dicing capacity in dicerwt cells was sufficient to
compensate for TN/TX, whereas in dicerex5 cells, impaired
miRNA-generating activity revealed TN/TX function. Collectively,
these findings indicate that TN/TX is integral to miRNA depletion
in dicer deficiency.
To determine if the observed differences in miRNA expression
impacted downstream miRNA function, miRNA-mediated
silencing assays were conducted. dicerwt cells expressed rela-
tively high levels of miR-21 and strongly suppressed expression
of amiR-21 reporter relative to dicerex5 cells (Figures 5G and 5H).
Knockdown of TN/TX in dicerex5 cells partially restored miR-21
andmiR-21-mediated silencing. Collectively, these findings indi-
cate that loss of miRNA in dicer deficiency is due to both loss ofhors
Pre-
miRNA
miRNA
Degraded
Products
Translin
Trax
Actin
Dicer
TRBP
pre-409
miR-409
5s rRNA
pri-409
wt
tn
A B
C D
miRR
el
at
iv
e
E
xp
re
ss
io
n
0
100
200
300
400
500
pre-
* *
pri-
wt tn wt tn wt tn wt tn
wt tn wt tn
Figure 4. Pre-miRNA Degradation by TN/TX Competes with Pre-
miRNA Processing by Dicer/TRBP In Vivo
(A) Immunoblotting performed with testis extracts from two pairs of wild-type
(wt) and translin (tn)/ mice.
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two pairs of wt and tn/ mice.
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from wt (black bars) and tn/mice (gray bars). *Greater than wt (p% 0.02; n =
3; means ± SD). See also Table S3.miRNA-generating activity and catabolic function of TN/TX.
Importantly, inhibition of TN/TX can, at least in part, reverse
these defects.
Inhibition of TN/TX Rescues dicer Haploinsufficiency
Laboratory and clinical studies have established dicer as a hap-
loinsufficient tumor suppressor (Kumar et al., 2007, 2009; Merritt
et al., 2008; Hill et al., 2009). Our findings of a catabolic cause of
miRNA loss in dicer deficiency raised the possibility that TN/TX
may also underlie loss of tumor suppressor activity. In HCT116
colon carcinoma cells, Dicer did not exhibit tumor suppressor
activity. That is, we did not observe differences in cell prolifera-
tion or colony formation between dicerwt and dicerex5 cells.
Importantly, these outcomes were also unaltered by TN/TX (Fig-
ures S2D and S2E).
To determine if TN/TX promotes loss of tumor suppressor ac-
tivity in dicer deficiency, wemade use of a previously established
model wherein Dicer functions as a tumor suppressor (Kumar
et al., 2009; Ravi et al., 2012; Mito et al., 2013). KrasG12D;
p53/ sarcoma cells encoding either dicer+/+ (KP) or dicer+/
(KP-D) were isolated from primary mouse tumors (Mito et al.,
2013). Monoallelic deletion of dicer was reflected in lower levels
of Dicer and miRNA-generating activity in KP-D versus KP cells
(Figures 6A and 6B). KP-D cells proliferated more rapidly (Fig-
ure 6C) and formed colonies more efficiently (Figures 6D and
6E) and more densely relative to KP cells (Figure 6F). These find-
ings are consistent with impaired tumor suppressor function of
dicer in KP-D versus KP cells and mirror the more aggressiveCell Repathology observed for KP-D versus KP tumors (Kumar et al.,
2009; Ravi et al., 2012; Mito et al., 2013).
We established stable knockdown of TN/TX using lentivirus-
mediated shRNA expression in KP and KP-D cells (Figures 7A
and 7B). Similar to HCT116 cells, depletion of TN and TX atten-
uated pre-miRNA degradation and enhancedmiRNA-generating
activity for both KP and KP-D cells (Figures 7C and 7D). miRNA
profiling also revealed patterns similar to those for HCT116 cells.
In dicer+/+ KP cells, TN/TX had only minor influence on miRNA
expression (Figure 7E, blue bars). However, in dicer-deficient
KP-D cells, miRNA that were most strongly downregulated rela-
tive to KP cells were those most markedly suppressed by TN/TX
(Figures 7E and 7F; Table S5). miRNA-specific assays supported
these profiling studies (Figure S3).
Importantly, TN/TX promoted loss of tumor suppressor activity
in dicer-deficient KP-D cells. Inhibition of TN/TX reduced cell
proliferation in KP-D, but not KP cells (Figure 7G). Similarly,
depletion of TN/TX attenuated efficiency and density of colony
formation in KP-D cells (Figures 7H and 7I). Collectively, these
findings indicate that loss of both miRNA and tumor suppressor
function with dicer haploinsufficiency was due to the combined
loss of miRNA-generating activity and TN/TX. Notably, inhibition
of TN/TX, at least in part, reversed these defects.
DISCUSSION
Human diseases are increasingly linked to genetic defects in
dicer. Loss of miRNA in dicer deficiency is thought to be due
to loss of miRNA-generating activity. In the current study, we
demonstrate that loss of miRNA in dicer deficiency is due
to both the expected loss of miRNA-generating activity and
TN/TX. This catabolic mechanism, integral to dicer deficiency,
advances understanding of miRNA depletion in tumor develop-
ment and may represent a general mechanism for other dicer
disorders.
Wholesale miRNA depletion promotes tumor development
through derepression of proliferative and embryonic cellular pro-
gramming (Lu et al., 2005; Kanellopoulou et al., 2005; Thomson
et al., 2006; Wang et al., 2007). Varied mechanisms contributing
to miRNA downregulation in diverse tumor types have been re-
ported (He et al., 2007; Chang et al., 2008, 2013; Heo et al.,
2008, 2009; Viswanathan et al., 2008, 2009; Hagan et al., 2009;
Paroo et al., 2009; Martello et al., 2010; Xhemalce et al., 2012;
Mori et al., 2014). However, genetic defects of themiRNA-gener-
ating machinery represent a general mechanism. Indeed, loss-
of-function mutations have been reported for trbp (Melo et al.,
2009), exportin-5 (Melo et al., 2010), and dicer (Hill et al., 2009;
Foulkes et al., 2011; Rio Frio et al., 2011; Heravi-Moussavi
et al., 2012). However, these mutations are very rare. In contrast,
hemizygous deletion of dicer is frequently found across tumor
types (Table S1; Kumar et al., 2009). Our studies reveal that
loss of both miRNA and tumor suppression with dicer haploin-
sufficiency is due to the expected loss of miRNA-generating
activity and complementary catabolic function of TN/TX.
Historically, TN/TX was known to function as a noncatalytic
nucleic acid interacting complex. Advanced structural modeling
suggested the presence of a possible nucleolytic motif (Liu
et al., 2009). Biochemical studies established TN/TX as anports 9, 1471–1481, November 20, 2014 ª2014 The Authors 1475
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Figure 5. Loss of miRNA in dicer Deficiency
Is due to Loss of miRNA-Generating Activity
and TN/TX
HCT116 human colon carcinoma cells encoding
wild-type (wt) or dicer hypomorph alleles (ex5)
were used to generate subcell lines stably ex-
pressing shRNA against luciferase (shluc), translin
(shTN), or trax (shTX).
(A and B) (A) Immunoblotting performed with ex-
tracts from dicerwt and (B) dicerex5 cells.
(C and D) (C) Pre-miRNA processing assays per-
formed with 20 mg of extract from dicerwt and (D)
dicerex5 cells.
(E) Histogram summary of miRNA profiling studies.
Data are presented as ratios of miRNA expression
for shTN relative to shluc for dicerwt (blue bars) and
dicerex5 cells (red bars). These values represent
the degree of miRNA suppression by TN/TX. The
dashed line indicates equivalent miRNA levels for
shTN and shluc. See also Table S4.
(F) Scatterplot representation of miRNA respon-
siveness to Dicer and TN/TX. Data are fold change
in miRNA for dicerex5 versus dicerwt (horizontal
axis) and shTN versus shluc for dicerex5 cells
(vertical axis). Closed circles represent miRNA
with 2-fold or greater decrease in dicerex5 versus
dicerwt. Open circles represent miRNA with less
than 2-fold decrease in dicerex5 versus dicerwt. The
correlation coefficient of the regression line for all
data points is 0.94 (p < 0.0001).
(G andH) (G) Relative expression ofmiR-21 and (H)
a miR-21 target reporter. *Higher miRNA expres-
sion for shTN and shTX compared with shluc in
dicerex5 cells (p < 0.025). #Lower miRNA-target
expression in shTN and shTX versus shluc in
dicerex5 cells (p < 0.001; n = 4; means ± SD).endonuclease with a role in siRNA programming of Argonaute2
(Liu et al., 2009; Ye et al., 2011). However, this function of TN/
TX may be limited to specific experimental contexts. For
example, TN/TX was not found to influence siRNA-mediated
silencing in Neurospora (Li et al., 2012). Similarly, we found no
role for TN/TX (or Dicer) in promoting siRNA-induced silencing
in HCT116 dicerwt, dicerex5, KP, or KP-D cells (Table S6).
A key finding of our studies was rescuing loss of both miRNA
and tumor suppressor activity with dicer haploinsufficiency
through inhibition of TN/TX. As is the case for some nucleases,
TN/TX may act on multiple classes of substrates. For example,
TN/TX was found to influence tRNA processing in Neurospora
and mouse embryonic fibroblasts (Li et al., 2012). Importantly,
the cellular effects of TN/TX reported here were entirely Dicer
dependent. First, TN/TX did not alter cell proliferation or colony1476 Cell Reports 9, 1471–1481, November 20, 2014 ª2014 The Authorsformation in fully functional dicer contexts
including dicerwt HCT116 colon carci-
noma cells or dicer+/+ KP sarcoma cells.
Second, Dicer did not exhibit tumor sup-
pressor activity in HCT116 cells, and,
despite broadly suppressing miRNA in
dicerex5 cells, TN/TX exhibited little influ-
ence on cell behavior. Third, loss of tumor
suppressor activity in dicer-deficientKP-D sarcoma cells was reversed by TN/TX inhibition. Collec-
tively, our findings indicate that the molecular and cellular func-
tions of TN/TX specifically oppose those of Dicer and are integral
to loss of both miRNA and tumor suppressor function with dicer
insufficiency.
In advancing understanding of themechanisms drivingmiRNA
depletion in dicer deficiency, our studies reveal a possible ther-
apeutic solution. Although there is much hope for oligonucleo-
tide-based miRNA therapeutics, pharmacodynamic challenges
persist. In contrast, TN/TX represents a potentially druggable
target for restoring global miRNA function for dicer disorders.
Moreover, because TN/TX exhibited limited effects in wild-type
dicer contexts, such therapy may enable selective action in
dicer-impaired cells for the treatment of dicer deficiencies
including aging, cancer, diabetes, and neurodegeneration.
Pre-
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at 2.53 magnification.EXPERIMENTAL PROCEDURES
General Procedures
Antibodies against Actin, Dicer, Translin, and Trax were obtained from Ab-
cam. TRBP antiserum was raised against purified full-length recombinant
TRBP. Site-directed mutagenesis was performed using the ‘‘QuikChange’’
system from Stratagene. RNase A and RNase T1 were purchased from
Invitrogen.
Pre-miRNA Processing and Pre-miRNA Complex Formation Assays
Synthetic pre-miRNA and sh-miRNA were synthesized by Dharmacon and
IDT. Pre-miRNAwas 50 end-labeledwith g-P32 ATP using T4 polynucleotide ki-
nase (New England Biolabs) and PAGE purified. Assays were performed with
pre-miR-16 except for experiments reported in Figure 3 as specified. Assays
were conducted in 100 mM KCl, 20 mM Tris, and 3 mM MgCl2 at 37
C for
15 min. RNA was phenol-chloroform extracted, ethanol precipitated, and
resolved on 7 M urea, 16% polyacrylamide gels. Pre-miRNA complex forma-
tion assays were performed as in vitro miRNA-generating assays but without
MgCl2 and with 2.5 mM EDTA to prevent substrate cleavage. Following incu-
bation, reactions were immediately loaded on to 4.5% native polyacrylamide
gels.
Fractionation and Purification of Pre-miRNA Degrading Activity
HeLa cell pellet was obtained from National Cell Culture Center. Ammonium
sulfate precipitation was performed by saturating HeLa S100 extract with
40% salt. Following rotation for 1 hr at 4C, soluble and pellet fractions
were resolved by centrifugation at 20,000 3 g at 4C for 20 min. The pellet
fraction was resuspended in the original volume with buffer A. Following dial-
ysis, equal volumes of each fraction were used for pre-miRNA processing
assays.
Fifty liters of culture was used to develop the purification scheme, and 25 l
of culture was used for the final purification procedure. Cells were lysed in
four times pellet volume of buffer A with protease inhibitors including 1 mM
Pefabloc SC, 5 mg/ml Leupeptine, and 0.7 mg/ml Pepstatin (Roche). AfterCell Reports 9, 1471–1481, Nositting on ice for 20 min, cells were broken with
40 strokes in a douncer followed by a 20,000 3
g spin at 4C for 30 min. The supernatant was
further centrifuged at 100,000 3 g for 1 hr at
4C to make S100.
All purification steps were carried out at 4C. All
columns were purchased from Pharmacia except
for the fluoroapatite column, which was obtained
from Bio-Rad. S100 was precipitated by ammo-nium sulfate at 40% saturation. After a 30min 20,0003 g spin, the supernatant
was diluted with 20% ammonium sulfate and loaded on to a 10 ml HiTrap
phenyl column over 14 column runs. Pre-miRNA degrading activity was eluted
with 7% ammonium sulfate, and fractions were precipitated by 60% ammo-
nium sulfate saturation. After a 30 min 20,000 3 g spin, the pellet was resus-
pended in 20% ammonium sulfate and loaded on to a 10 ml HiTrap octyl
column over three column runs. Pre-miRNA degrading activity was eluted
with 8% ammonium sulfate and loaded on to a 26/60 Superdex 200 column.
Fractions were assayed for pre-miRNA processing and active fractions were
loaded on to a 5 ml fluoroapatite column. Peak activity was eluted between
70 and 100 mM potassium phosphate and directly loaded on a Q Sepharose
column. Fractions were assayed for pre-miRNA degrading activity, resolved
on SDS-polyacrylamide gels, and silver stained (Invitrogen). Bands depicted
in Figure 2C were excised with a razor blade and destained. Protein identifica-
tion was performed by Applied Biomics.
Preparation of Recombinant Protein Complexes
Wild-type and catalytic mutant (E126A) His-Trax and Translin complexes were
coexpressed in BL21 cells using the pETDuet-1 vector. Cultures were
expanded at 37C to an OD600 of 0.4. Induction was carried out in 1 mM iso-
propyl b-D-1-thiogalactopyranoside for 10 hr at 16C. Cells were harvested
and lysed by sonication in 20mM Tris-HCl (pH 8.0), 50 mMNaCl, 5 mM b-mer-
captoethanol, and protease inhibitors. S20 (20,000 3 g supernatant) lysates
were incubated with Ni-NTA beads (QIAGEN) overnight, loaded on to a collect-
ing column, and washed sequentially with 75 vol buffer B (buffer A + 1 M NaCl)
and 25 vol buffer A containing 20 mM imidazole. After a final 50 mM imidazole
wash, proteins were eluted in buffer A + 250 mM imidazole. Complexes were
further purified by Q Sepharose and Superdex 200 columns and stored in
aliquots containing 10% glycerol at –80C. Recombinant Dicer/TRBP was
prepared as described (Paroo et al., 2009).
Animal Procedures
A colony of translin/ mice was established at Johns Hopkins from the line
generated in Dr. M. Kasai’s laboratory (Fukuda et al., 2008). These mice had
been backcrossed to C57/BL6 for over ten generations. The translin KOvember 20, 2014 ª2014 The Authors 1477
shluc
R
el
at
iv
e
C
el
l#
0
1000
2000
3000
4000
shTN shTX shluc shTN shTX
KP KP-D
*
shluc
C
ol
on
ie
s
0
2
4
6
8
10
shTN shTX shluc shTN shTX
KP KP-D
E
G
F
KP
KP-D
shluc shTN shTX
*
No luc2 TN TX
Pre-
miRNA
miRNA
Degraded
Products
shRNAshRNA
Degraded
Products
Translin
Dicer
Actin
No luc2 TN TX
Trax
KP
Translin
Dicer
Actin
No luc2 TN TX
Trax
KP-D
shRNA shRNA
No luc2 TN TX
KP KP-D
Pre-
miRNA
miRNA
miRNA
0
1
2
3
4
5
6
7
8A B
C D
H I
KP
KP-D
Fo
ld
Δ
(s
hT
N
vs
sh
lu
c)
0
2
4
6
8
0.25 0.50 0.75 1.00
Highdicer response
Lowdicer response
Fo
ld
Δ
(s
hT
N
vs
sh
lu
c)
Fold Change (KP-D vs KP)
Figure 7. Inhibition of TN/TX Rescues Loss of Both miRNA and Tumor Suppressor Activity in dicer Haploinsufficiency
KrasG12D; p53/ mouse sarcoma cells encoding either dicer+/+ (KP) or dicer+/ (KP-D) were used to generate subcell lines stably expressing shRNA against
luciferase (shluc), translin (shTN), or trax (shTX).
(A and B) (A) Immunoblotting performed with extracts from KP and (B) KP-D cells.
(C and D) (C) Pre-miRNA processing assays performed with 20 mg of extract from KP and (D) KP-D cells.
(E) Histogram summary of miRNA profiling studies. Data are presented as ratios of miRNA expression for shTN relative to shluc for KP (blue bars) and KP-D cells
(red bars). These values represent the degree of miRNA suppression by TN/TX. The dashed line indicates equivalent miRNA levels for shTN and shluc. See also
Table S5.
(F) Scatterplot representation of miRNA responsiveness to Dicer and TN/TX. Data are fold change for miRNA downregulated in KP-D versus KP cells (horizontal
axis) and shTN versus shluc for KP-D cells (vertical axis). Closed circles represent miRNA with 2-fold or greater decrease in KP-D versus KP. Open circles
represent miRNA with less than 2-fold decrease in KP-D versus KP. The correlation coefficient of the regression line for all data points is 0.89 (p < 0.0001).
(G) For proliferation studies, cells were plated and incubated overnight, and baseline counts were taken the next day (0 hr). Cell populations at 72 hr were
normalized to those at 0 hr. *Higher cell counts for shluc versus shTN and shTX in KP-D cells (p < 0.003; n = 3; means ± SD).
(H) Cells were plated at clonal density (500 cells per 6-well plate) and incubated for 8 days. *Greater colony formation for shluc versus shTN and shTX in KP-D cells
(p < 0.025; n = 3; means ± SD).
(I) Representative images of colony density at 2.53 magnification.mice (Nbio055) were provided by the JCRB Laboratory Animal Resource Bank
of the National Institute of Biomedical Innovation. Genotyping of mice was per-
formed on DNA isolated from tail snips. PCRwas conducted using the primers
and conditions described by Fukuda et al. (2008). Three- to 4-month-old male
mice were sacrificed by decapitation with a small animal guillotine. Cerebella
were rapidly removed and frozen on a dry ice/ethanol slurry. Animal housing
and procedures adhered to American Association for Laboratory Animal Sci-
ence guidelines.
shRNA, Lentivirus, and Cell-Culture Procedures
DNA oligos for shRNA were cloned in to the pGreenPuro vector (SBI). Four se-
quences against each of TN and TX were tested for knockdown efficiency in1478 Cell Reports 9, 1471–1481, November 20, 2014 ª2014 The Auttransient transfection studies. Transfections were performed using Lipofect-
amine 2000 (Invitrogen). The most potent sequence for each was selected
for lentivirus production. Sequences used were as follows:
shluc1: 50-gatcgatttcgagtcgtcttaatttcaagagaattaagacgactcgaaatctttttg -30
shluc2: 50-gatcgattatgtccggttatgtattcaagagatacataaccggacataatctttttg- 30
shTN (human/mouse): 50-gatctgctaaacactgcgctttatttcaagagaataaagcg
cagtgtttagcatttttg -30
shTX (human): 50-gatcgctttcctattctagcatttattcaagagataaatgctagaatag
gaaagctttttg- 30
shTX (mouse): 50- gatctgtatatgtgctcgctctattttcaagagaaatagagcgagcaca
tatacatttttg- 30hors
shRNA vectors were cotransfected with packaging vectors (SBI) in 293TN
cells. Pseudoviral particles were collected at 48 and 72 hr posttransfection
and concentrated. Viral titers were assessed in target cells using the Global
UltraRapid Lentiviral Titering kit (SBI). To achieve single-copy integration per
cell, cells were transducedwith viral particles and Transdux (SBI) at amultiplic-
ity of infection of 0.25. After 72 hr, cell selectionwas initiatedwith growthmedia
containing 2 mg/ml puromycin for 10 days.
For phenotypic assays, cells were trypsinized, washed with PBS, and
resuspended in DMEM containing 0% fetal bovine serum (FBS). For prolif-
eration assays, 500 cells were added to 96-well plates containing 100 ml of
media with a 2 3 serum concentration (10% FBS for HCT116 cells, 5% FBS
for sarcoma cells) in a volume of 100 ml. Cells were incubated overnight and
counted the next day for baseline readings. Counts at 72 hr were normal-
ized to those at 0 hr. Cell counts were assayed using a Cell Titer Glo lumi-
nescent cell viability assay (Promega). For colony formation assays, 500
cells were added to 6-well plates containing the minimum serum concentra-
tion required for clonal growth (5% FBS for HCT116 cells, 2.5% FBS for
sarcoma cells). Colonies were typically cultured for 8 days, fixed, and
stained with crystal violet, and clones greater than 1 mm in diameter were
counted.
miRNA Analysis
As cell-culture parameters have been shown to influence miRNA expression
(Hwang et al., 2009), RNA was prepared from cultures at 60% confluency
and 48 hr postplating. Total RNA was isolated using Trizol (Invitrogen). miRNA
profiling was performed by Exiqon using miRCURY LNA Universal RT miRNA
PCR human or mouse panel I. For cell lines, analysis was performed using
pooled replicates for each experimental group. Statistical analyses were
performed by Exiqon.
miRNA qPCR was performed using the Universal cDNA synthesis kit II,
LNA PCR primer sets, and ExiLENT SYBR green master mix (Exiqon). Small
RNA northern blotting was performed with 10 mg of total RNA from each
mouse cerebellum. RNA was resolved on 7 M urea, 16% polyacrylamide
gels, transferred to Zeta-Probe membrane (Bio-Rad), and subjected to UV
crosslinking. Membranes were prehybridized using Ultrahyb-Oligo buffer
(Invitrogen) at 42C. Hybridization was conducted at 42C overnight followed
by two washes in 2 3 saline sodium citrate (SSC) and 0.1% SDS and one
wash in 0.5 3 SSC and 0.1% SDS. RNA oligos were used as probes for hy-
bridization. Oligos were 50 end labeled with g-32P-ATP by T4 polynucleotide
kinase (NEB). Probes were stripped by pouring boiling 0.1 3 SSC and 0.1%
SDS over membranes.
Silencing Assays
miRNA-mediated silencing assays were conducted by cotransfecting cells
with constructs encoding either firefly luciferase (FL) or firefly luciferase under
the control of miR-21 (FL-21) and Renilla luciferase (RL) as a transfection con-
trol (Yi et al., 2003). Reporter activity was assayed using a Dual Luciferase Re-
porter System (Promega). Reporter expression was determined by the ratio of
(FL-21/RL) to (FL/RL). siRNA-induced silencing assays were conducted by co-
transfecting cells with constructs encoding FL, RL, and 0–1 nM siRNA against
FL. FL activity was normalized to RL, and percentage of inhibition was plotted
against siRNA concentration.
Statistical Analysis
Experiments were typically run in triplicate and repeated in a minimum of three
independent trials. Image quantitation was performed using ImageJ analysis
software (NIH). Data are represented as means ± SD, unless otherwise stated.
Student’s t tests were employed where the minimum level of significance was
p < 0.05. Regression analyses and IC50 calculations were performed with
Sigma Plot 11.0.
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